

Improve Diversity in Critical Care Medicine
The Issue
The Issue
The February 23, 2016 issue of the Journal of the American Medical Association (JAMA) devoted to critical care is a major achievement. However, we were disappointed to see that the Sepsis-3 consensus panel, convened with the support of major national and international critical care societies to formulate a new definition for sepsis, included no women, no under-represented minority members, and no members from developing countries.(1) This panel came on the heels of another invited consensus group convened a few years ago to address the definition of the Acute Respiratory Distress Syndrome that included only one woman out of 15 Task Force members, and lacked representation from countries beyond North America and Western Europe.(2)
There are presently many accomplished academic intensivists who are women and/or underrepresented minorities, and who work outside of Europe and North America; however, it is unclear if intensivists with these demographics were considered in the formation of the Sepsis-3 consensus panel. Importantly, diversity does not, and should not, come at the expense of academic excellence. But the willingness to look beyond traditional circles for expertise is a necessity in 2016.
A Solution
Consensus panels convened by invitation have a unique opportunity to ensure inclusive leadership that is representative of the whole community within critical care. Moreover, extensive research has demonstrated that with diversity of participants comes diversity of ideas, enhanced innovation, and improved group performance (3,4)--something any expert panel should welcome. We suggest that societies sponsoring such panels ensure a transparent selection process to ensure that diversity is valued and relative homogeneity is explained.
With an increasing number of medical school graduates now women and minorities,(5) critical care can and must attract the very best of these groups to the field to retain relevance. To look at the recent JAMA publications may very well leave talented women and minorities feeling they cannot see a career path within critical care, resulting in their selecting other specialties; this would be a huge loss. Invitation-only consensus panels are well-positioned to actively cultivate diversity, and explicitly mentor rising investigators into leadership roles. We encourage professional organizations and academicians to pro-actively engage in a larger conversation directed at finding ways for the field of critical care to open its doors and provide a face to the world promoting diversity.
This letter was written on behalf of the American Thoracic Society’s Working Group of Women in Critical Care and the Subcommittee on Health Equality and was published on July 26, 2016 in JAMA.(6) Over 60 individuals in academic critical care have given their support for it already. Please show your support for diversity in Critical Care Medicine by signing this statement with us.
Supporters
Raolat M. Abdulai, MD; Harvard Medical School-Brigham and Women's Hospital, USA
Kathleen Akgun, MD MS; Yale School of Medicine, USA
Rebecca Aslakson, MD PhD; Johns Hopkins University, USA
Becky Baron, MD; Brigham and Women's Hospital, USA
Julie Bastarache, MD; Vanderbilt University, USA
Estaban G. Burchard, MD MPH; University of California, San Francisco, USA
Ellen Burnham, MD MS; University of Colorado School of Medicine, USA
Carolyn S. Calfee, MD; University of California, San Francisco, USA
Shannon Carson, MD; University of North Carolina, USA
Juan C. Celedon, DrPH, MD; University of Pittsburgh, Children's Hospital of Pittsburgh, USA
Jason Christie, MD MS; University of Pennsylvania, USA
Geoffrey Connors, MD; Yale School of Medicine, USA
Colin Cooke, MD MS; University of Michigan, USA
Christopher E. Cox, MD MPH; Duke University, USA
Janet Diaz, MD; California Pacific Medical Center, USA
Ivor Douglas, MD; University of Colorado School of Medicine, USA
E. Wesley Ely, MD MPH; Vanderbilt University, USA
Elisa Estessoro, MD; Hospital Interzonal de Agudos San Martin, La Plata, BA Argentina
Laura E. Evans, MD MSc; NYU School of Medicine, Bellevue Hospital Center, USA
Thomas W. Ferkol Jr., MD; Washington University, USA
Simon Finfer, MD; University of Sydney, Australia
Joe N.G. (Skip) Garcia, MD; University of Arizona Health Sciences, USA
Allan Garland, MD MA; University of Manitoba, Canada
Hayley B. Gershengorn, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Timothy Girard, MD; Vanderbilt University, USA
Antonio Gomez, MD; University of California, San Francisco, USA
Michelle N. Gong, MD MS; Albert Einstein College of Medicine, Montefiore Medical Center, USA
David Gozal, MD MBA; University of Chicago, USA
Jesse R. Hall, MD; University of Chicago, USA
Scott Halpern, MD PhD; University of Pennsylvania, USA
John Hansen-Flaschen, MD; University of Pennsylvania, USA
Nicholas Hart, MRCP MBBS PhD; St Thomas' Hospital, UK
Shyoko Honiden, MD; Yale School of Medicine, USA
Aluko A. Hope, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Catherine L. Hough, MD MSc; University of Washington, USA
S. Jean Hsieh, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
May Hua, MD; Columbia University Medical College, USA
T. Jack Iwashyna, MD PhD; University of Michigan, USA
Meshell D. Johnson, MD; University of California, San Francisco, USA
Jeremy Kahn, MD MS; University of Pittsburgh, USA
Kirsten Kangelaris, MD; University of California, San Francisco, USA
Meeta Kerlin, MD MSCE; University of Pennsylvania, USA
Nita Khandelwal, MD; University of Washington, USA
Vladimir Kvetan, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Meghan Lane-Fall, MD MSHP; University of Pennsylvania, USA
Abbey Lara, MD; University of Colorado School of Medicine, USA
Joe Levitt, MD MS; Stanford University, USA
Janice Liebler, MD; University of Southern California, USA
Kathleen Liu, MD; University of California, San Francisco, USA
Sarah M. Lyon, MD MSCE; University of Pennsylvania, USA
Aline Maddux, MD; University of Colorado School of Medicine, USA
Atul Malhotra, MD; University of California, San Diego, USA
Michael Matthay, MD; University of California, San Francisco, USA
Richard Matthay, MD; Yale University, USA
Nuala J. Meyer, MD; University of Pennsylvania, USA
Smita Pakhale, MD MSc FRCPC; Ottawa Hospital, Canada
Pratik Pandharipande, MD; Vanderbilt University, USA
Hallie C. Prescott, MD MSc; University of Michigan, VA Ann Arbor, USA
Kristin A. Riekert, PhD; Johns Hopkins University, USA
Katherine Rivera-Spolijaric, MD; Washington University, USA
William Rodriguez, MD; VA San Juan, USA
Jesse Roman-Rodriguez, MD FACP FACCP; University of Louisville, USA
Kari L. Rosbeck; Tuberous Sclerosis Alliance, USA
Kathy Rowan, PhD MSc; Intensive Care National Audit & Research Centre, UK
Jonathan M. Samet, MD MS; University of Southern California, USA
Dean E. Schraufnagel, MD; University of Illinois College of Medicine, USA
Dean Sheppard, MD; University of California, San Francisco, USA
Mark Siegel, MD; Yale School of Medicine, USA
Kerri A. Smith, MD; University of Pennsylvania, USA
Renda Soylemez Wiener, MD MPH; Boston University School of Medicine, USA
H. Thomas Stelfox, MD PhD FRCPC; University of Calgary, Canada
Eleanor Summerhill, MD; Lahey Hospital and Medical Center, MD
Alvin V. Thomas Jr., MD; Howard University Hospital, USA
Dona J. Upson, MD MA; University of New Mexico School of Medicine, USA
Lisa K. Vande Vusse, MD MSc; University of Washington, USA
Adrian Velasquez, MD MPH; Newport Hospital, USA
Allan J. Walkey, MD MSc; Boston University School of Medicine, USA
Angela Wang, MD; Scripps Clinic, USA
Lorraine Ware, MD; Vanderbilt University, USA
Ann Weinacker, MD; Stanford University, USA
Douglas B. White, MD MAS; University of Pittsburgh, USA
Jeanine P. Wiener-Kronish, MD; Massachusetts General Hospital, USA
Jennifer Wilson, MD; University of California, San Francisco, USA
Hannah Wunsch, MD MSc; University of Toronto, Canada
Guy A. Zimmerman, MD; University of Utah, USA
References
1. Singer M, Deutschman CS, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801---810.
2. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. Jun 20 2012;307(23):2526---2533.
3. Dezso CL, Ross DG. Does female representation in top management improve firm performance? A panel data investigation. Strat Manage J. 2012; 33 (9): 1072---89.
4. Richard OC. Racial diversity, business strategy, and firm performance: A resource--- based view. Acad Manage J. 2000; 43(2): 164---77.
5. AAMC. Diversity in the Physician Workforce: Facts & Figures 2014. Washington, DC: Association American Medical Colleges;2014.
6. Burnham EL and Roman J. JAMA. 26 Jul 2016;(316(4):460-1.
Petition Closed
The Issue
The Issue
The February 23, 2016 issue of the Journal of the American Medical Association (JAMA) devoted to critical care is a major achievement. However, we were disappointed to see that the Sepsis-3 consensus panel, convened with the support of major national and international critical care societies to formulate a new definition for sepsis, included no women, no under-represented minority members, and no members from developing countries.(1) This panel came on the heels of another invited consensus group convened a few years ago to address the definition of the Acute Respiratory Distress Syndrome that included only one woman out of 15 Task Force members, and lacked representation from countries beyond North America and Western Europe.(2)
There are presently many accomplished academic intensivists who are women and/or underrepresented minorities, and who work outside of Europe and North America; however, it is unclear if intensivists with these demographics were considered in the formation of the Sepsis-3 consensus panel. Importantly, diversity does not, and should not, come at the expense of academic excellence. But the willingness to look beyond traditional circles for expertise is a necessity in 2016.
A Solution
Consensus panels convened by invitation have a unique opportunity to ensure inclusive leadership that is representative of the whole community within critical care. Moreover, extensive research has demonstrated that with diversity of participants comes diversity of ideas, enhanced innovation, and improved group performance (3,4)--something any expert panel should welcome. We suggest that societies sponsoring such panels ensure a transparent selection process to ensure that diversity is valued and relative homogeneity is explained.
With an increasing number of medical school graduates now women and minorities,(5) critical care can and must attract the very best of these groups to the field to retain relevance. To look at the recent JAMA publications may very well leave talented women and minorities feeling they cannot see a career path within critical care, resulting in their selecting other specialties; this would be a huge loss. Invitation-only consensus panels are well-positioned to actively cultivate diversity, and explicitly mentor rising investigators into leadership roles. We encourage professional organizations and academicians to pro-actively engage in a larger conversation directed at finding ways for the field of critical care to open its doors and provide a face to the world promoting diversity.
This letter was written on behalf of the American Thoracic Society’s Working Group of Women in Critical Care and the Subcommittee on Health Equality and was published on July 26, 2016 in JAMA.(6) Over 60 individuals in academic critical care have given their support for it already. Please show your support for diversity in Critical Care Medicine by signing this statement with us.
Supporters
Raolat M. Abdulai, MD; Harvard Medical School-Brigham and Women's Hospital, USA
Kathleen Akgun, MD MS; Yale School of Medicine, USA
Rebecca Aslakson, MD PhD; Johns Hopkins University, USA
Becky Baron, MD; Brigham and Women's Hospital, USA
Julie Bastarache, MD; Vanderbilt University, USA
Estaban G. Burchard, MD MPH; University of California, San Francisco, USA
Ellen Burnham, MD MS; University of Colorado School of Medicine, USA
Carolyn S. Calfee, MD; University of California, San Francisco, USA
Shannon Carson, MD; University of North Carolina, USA
Juan C. Celedon, DrPH, MD; University of Pittsburgh, Children's Hospital of Pittsburgh, USA
Jason Christie, MD MS; University of Pennsylvania, USA
Geoffrey Connors, MD; Yale School of Medicine, USA
Colin Cooke, MD MS; University of Michigan, USA
Christopher E. Cox, MD MPH; Duke University, USA
Janet Diaz, MD; California Pacific Medical Center, USA
Ivor Douglas, MD; University of Colorado School of Medicine, USA
E. Wesley Ely, MD MPH; Vanderbilt University, USA
Elisa Estessoro, MD; Hospital Interzonal de Agudos San Martin, La Plata, BA Argentina
Laura E. Evans, MD MSc; NYU School of Medicine, Bellevue Hospital Center, USA
Thomas W. Ferkol Jr., MD; Washington University, USA
Simon Finfer, MD; University of Sydney, Australia
Joe N.G. (Skip) Garcia, MD; University of Arizona Health Sciences, USA
Allan Garland, MD MA; University of Manitoba, Canada
Hayley B. Gershengorn, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Timothy Girard, MD; Vanderbilt University, USA
Antonio Gomez, MD; University of California, San Francisco, USA
Michelle N. Gong, MD MS; Albert Einstein College of Medicine, Montefiore Medical Center, USA
David Gozal, MD MBA; University of Chicago, USA
Jesse R. Hall, MD; University of Chicago, USA
Scott Halpern, MD PhD; University of Pennsylvania, USA
John Hansen-Flaschen, MD; University of Pennsylvania, USA
Nicholas Hart, MRCP MBBS PhD; St Thomas' Hospital, UK
Shyoko Honiden, MD; Yale School of Medicine, USA
Aluko A. Hope, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Catherine L. Hough, MD MSc; University of Washington, USA
S. Jean Hsieh, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
May Hua, MD; Columbia University Medical College, USA
T. Jack Iwashyna, MD PhD; University of Michigan, USA
Meshell D. Johnson, MD; University of California, San Francisco, USA
Jeremy Kahn, MD MS; University of Pittsburgh, USA
Kirsten Kangelaris, MD; University of California, San Francisco, USA
Meeta Kerlin, MD MSCE; University of Pennsylvania, USA
Nita Khandelwal, MD; University of Washington, USA
Vladimir Kvetan, MD; Albert Einstein College of Medicine, Montefiore Medical Center, USA
Meghan Lane-Fall, MD MSHP; University of Pennsylvania, USA
Abbey Lara, MD; University of Colorado School of Medicine, USA
Joe Levitt, MD MS; Stanford University, USA
Janice Liebler, MD; University of Southern California, USA
Kathleen Liu, MD; University of California, San Francisco, USA
Sarah M. Lyon, MD MSCE; University of Pennsylvania, USA
Aline Maddux, MD; University of Colorado School of Medicine, USA
Atul Malhotra, MD; University of California, San Diego, USA
Michael Matthay, MD; University of California, San Francisco, USA
Richard Matthay, MD; Yale University, USA
Nuala J. Meyer, MD; University of Pennsylvania, USA
Smita Pakhale, MD MSc FRCPC; Ottawa Hospital, Canada
Pratik Pandharipande, MD; Vanderbilt University, USA
Hallie C. Prescott, MD MSc; University of Michigan, VA Ann Arbor, USA
Kristin A. Riekert, PhD; Johns Hopkins University, USA
Katherine Rivera-Spolijaric, MD; Washington University, USA
William Rodriguez, MD; VA San Juan, USA
Jesse Roman-Rodriguez, MD FACP FACCP; University of Louisville, USA
Kari L. Rosbeck; Tuberous Sclerosis Alliance, USA
Kathy Rowan, PhD MSc; Intensive Care National Audit & Research Centre, UK
Jonathan M. Samet, MD MS; University of Southern California, USA
Dean E. Schraufnagel, MD; University of Illinois College of Medicine, USA
Dean Sheppard, MD; University of California, San Francisco, USA
Mark Siegel, MD; Yale School of Medicine, USA
Kerri A. Smith, MD; University of Pennsylvania, USA
Renda Soylemez Wiener, MD MPH; Boston University School of Medicine, USA
H. Thomas Stelfox, MD PhD FRCPC; University of Calgary, Canada
Eleanor Summerhill, MD; Lahey Hospital and Medical Center, MD
Alvin V. Thomas Jr., MD; Howard University Hospital, USA
Dona J. Upson, MD MA; University of New Mexico School of Medicine, USA
Lisa K. Vande Vusse, MD MSc; University of Washington, USA
Adrian Velasquez, MD MPH; Newport Hospital, USA
Allan J. Walkey, MD MSc; Boston University School of Medicine, USA
Angela Wang, MD; Scripps Clinic, USA
Lorraine Ware, MD; Vanderbilt University, USA
Ann Weinacker, MD; Stanford University, USA
Douglas B. White, MD MAS; University of Pittsburgh, USA
Jeanine P. Wiener-Kronish, MD; Massachusetts General Hospital, USA
Jennifer Wilson, MD; University of California, San Francisco, USA
Hannah Wunsch, MD MSc; University of Toronto, Canada
Guy A. Zimmerman, MD; University of Utah, USA
References
1. Singer M, Deutschman CS, Seymour C, et al. The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA. 2016;315(8):801---810.
2. Ranieri VM, Rubenfeld GD, Thompson BT, et al. Acute respiratory distress syndrome: the Berlin Definition. JAMA. Jun 20 2012;307(23):2526---2533.
3. Dezso CL, Ross DG. Does female representation in top management improve firm performance? A panel data investigation. Strat Manage J. 2012; 33 (9): 1072---89.
4. Richard OC. Racial diversity, business strategy, and firm performance: A resource--- based view. Acad Manage J. 2000; 43(2): 164---77.
5. AAMC. Diversity in the Physician Workforce: Facts & Figures 2014. Washington, DC: Association American Medical Colleges;2014.
6. Burnham EL and Roman J. JAMA. 26 Jul 2016;(316(4):460-1.
The Decision Makers
Petition Updates
Share this petition
Petition created on March 21, 2016